28 Apr After assessing and diagnosing a patient, PMHNPs must take into consideration special characteristics of the patient before determining an appropriate course of treatment. For pharma

LEARNING RESOURCES

Required Readings

· American Psychiatric Association. (2016).  The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementiaLinks to an external site. . https://doi.org/10.1176/appi.books.9780890426807

· Agency for Healthcare Research and Quality. (2019).  Maternal and fetal effects of mental health treatments in pregnant and breastfeeding women: A systematic review of pharmacological interventionsLinks to an external site. . https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf

· Hardy, L. T., & Reichenbacker, O. L. (2019).  A practical guide to the use of psychotropic medications during pregnancy and lactationLinks to an external site. .  Archives of Psychiatric Nursing,  33(3), 254–266. https://doi.org/10.1016/j.apnu.2019.04.001

· National Library of Medicine. (2006–2020).  Drugs and lactation databaseLinks to an external site.  (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501922/  

·

· The LactMed® database is a peer-reviewed, evidence-based resource on drugs that may be used by breastfeeding mothers. It includes possible effects on nursing infants and offers drug alternatives where possible. 

· Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015).  Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer.

·

· Chapter 27, “Psychiatry and Reproductive Medicine”

· Chapter 33, “Geriatric Psychiatry” 

· Stewart, J. G., & DeNisco, S. M. (2019).  Role development for the nurse practitioner (2nd ed.) . Jones & Bartlett Learning.

·

· Chapter 3, “Vulnerable Populations”

· Chapter 4, “Mental Health and Primary Care: A Critical Intersection”

· Chapter 5, “Cultural Sensitivity and Global Health”

TO PREPARE:

· Choose one of the two following specific populations: either pregnant women or older adults. Then, select a specific disorder from the  DSM-5-TR to use.

· Use the Walden Library to research evidence-based treatments for your selected disorder in your selected population (either older adults or pregnant women). You will need to recommend one FDA-approved drug, one non-FDA-approved “off-label” drug, and one nonpharmacological intervention for treating the disorder in that population.

THE QUESTION

· Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating your chosen disorder in older adults or pregnant women.

· Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?

· Explain whether clinical practice guidelines exist for this disorder, and if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.

· Support your reasoning with at least three current, credible scholarly resources, one each on the FDA-approved drug, the off-label, and a nonpharmacological intervention for the disorder.